Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Oncogene ; 25(2): 198-206, 2006 Jan 12.
Artigo em Inglês | MEDLINE | ID: mdl-16116474

RESUMO

Inducible nitric oxide synthase (iNOS) expression is regulated at both the transcriptional and post-transcriptional level in epithelial cells. The aim of this study was to characterize the effects of tyrosine phosphorylation on iNOS activity. In a human intestinal epithelial cell line stimulated with cytokines, tyrosine phosphorylation of human iNOS protein was observed after 30 min exposure to pervanadate (PV), an inhibitor of protein tyrosine phosphatases. 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine, a specific inhibitor of Src tyrosine kinases, abolished the PV-induced iNOS tyrosine phosphorylation. Cotransfection of Src with iNOS cDNA in human embryonic kidney (HEK) 293 cells resulted in a threefold (P<0.001) increase of iNOS protein levels and tyrosine phosphorylation of iNOS. In the presence of Src, 76% of wild-type (wt) iNOS was redistributed to detergent-insoluble domains and iNOS activity was decreased by 28% (P<0.05) despite increased iNOS protein levels. Analysis of iNOS tyrosine mutants revealed decreased Src-induced effects in Y151F iNOS mutant. Using a GST-fusion protein containing a domain encompassing Y151, we show that Y151 is a direct substrate for active Src in vitro. These findings indicate a role for iNOS tyrosine phosphorylation in the regulation of iNOS activity and the implication of Src tyrosine kinases in this pathway.


Assuntos
Células Epiteliais/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Óxido Nítrico Sintase Tipo II/metabolismo , Proteínas Proto-Oncogênicas pp60(c-src)/farmacologia , Frações Subcelulares/enzimologia , Sequência de Aminoácidos , Células Cultivadas , Inibidores Enzimáticos/farmacologia , Células Epiteliais/citologia , Células Epiteliais/enzimologia , Humanos , Immunoblotting , Imunoprecipitação , Mucosa Intestinal/citologia , Mucosa Intestinal/enzimologia , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Mutação/genética , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase Tipo II/genética , Fosforilação/efeitos dos fármacos , Proteínas Tirosina Fosfatases/antagonistas & inibidores , Homologia de Sequência de Aminoácidos , Transfecção , Tirosina/metabolismo , Vanadatos/farmacologia
2.
Carcinogenesis ; 21(2): 281-7, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10657969

RESUMO

Exposing the human bronchial epithelial cell line BEAS-2B to the nitric oxide (NO) donor sodium 1-(N,N-diethylamino)diazen-1-ium-1, 2-diolate (DEA/NO) at an initial concentration of 0.6 mM while generating superoxide ion at the rate of 1 microM/min with the hypoxanthine/xanthine oxidase (HX/XO) system induced C:G-->T:A transition mutations in codon 248 of the p53 gene. This pattern of mutagenicity was not seen by 'fish-restriction fragment length polymorphism/polymerase chain reaction' (fish-RFLP/PCR) on exposure to DEA/NO alone, however, exposure to HX/XO led to various mutations, suggesting that co-generation of NO and superoxide was responsible for inducing the observed point mutation. DEA/NO potentiated the ability of HX/XO to induce lipid peroxidation as well as DNA single- and double-strand breaks under these conditions, while 0.6 mM DEA/NO in the absence of HX/XO had no significant effect on these parameters. The results show that a point mutation seen at high frequency in certain common human tumors can be induced by simultaneous exposure to reactive oxygen species and a NO source.


Assuntos
Códon/genética , Dano ao DNA , Genes p53/efeitos dos fármacos , Hidrazinas/toxicidade , Doadores de Óxido Nítrico/toxicidade , Mutação Puntual , Espécies Reativas de Oxigênio , Antígenos Transformantes de Poliomavirus/fisiologia , Brônquios/citologia , Linhagem Celular Transformada , Códon/química , Fragmentação do DNA , Sinergismo Farmacológico , Células Epiteliais/química , Células Epiteliais/citologia , Genes p53/genética , Humanos , Hidrazinas/farmacologia , Hipoxantina/metabolismo , Peroxidação de Lipídeos , Óxido Nítrico/metabolismo , Doadores de Óxido Nítrico/farmacologia , Óxidos de Nitrogênio , Superóxidos/metabolismo , Xantina Oxidase/metabolismo
3.
Cell Growth Differ ; 8(2): 261-8, 1997 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9040948

RESUMO

Reactive oxygen species modulate the cell growth of a wide variety of mammalian cells. To determine whether oxidative metabolism is altered during the differentiation process, we studied the expression of pro- and antioxidant proteins in proliferating and differentiated CaCo-2 cells, a human colon adenocarcinoma cell line. Nitric oxide synthase type 2 (iNOS) produces nitric oxide (NO). Depending on its rate of synthesis, NO may either promote cellular and DNA damage or reduce the ability of other free radicals to induce cell injury. Using Western and Northern blot analysis and arginine conversion assay, we demonstrate that the expression of iNOS decreases when cells undergo differentiation. This biological event entails a diminished production of NO metabolites and correlates with the loss of activation of soluble guanylate cyclase activity. In differentiated cells, a 2-fold down-regulation of the nuclear factor kappa B activity was observed, suggesting that nuclear factor kappa B could be one of the iNOS gene regulatory factors in the CaCo-2 model. In parallel, we studied the expression of other antioxidant proteins including glutathione S-transferase alpha (GST alpha), bcl-2, and the metallothioneins (MTs). We show that the protein levels of GST alpha and MT increase during the differentiation of CaCo-2 cells, whereas bcl-2 levels decrease. Our investigation indicates that the expression of iNOS, GST alpha, bcl-2, and MT is associated with the enterocytic differentiation. The shift in the expression of specific antioxidant genes during CaCo-2 cell differentiation may occur to avoid alterations in the cell redox potential.


Assuntos
Glutationa Transferase/biossíntese , Metalotioneína/biossíntese , Óxido Nítrico Sintase/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Actinas/química , Western Blotting , Células CACO-2 , Diferenciação Celular/genética , Diferenciação Celular/fisiologia , GMP Cíclico/química , Indução Enzimática , Regulação da Expressão Gênica/fisiologia , Glutationa Transferase/genética , Humanos , Intestinos/citologia , Metalotioneína/genética , Modelos Biológicos , Óxido Nítrico Sintase/biossíntese , Óxido Nítrico Sintase/genética , Proteína Supressora de Tumor p53/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA